The Organon Access Program may be able to help
answer questions about access and support, including:
Benefit investigations and information about
prior authorizations and appeals
Co-pay assistance for eligible patients
Referral to the Organon Patient Assistance Program
for eligibility determination (provided through the
Organon Patient Assistance Program Inc.)
Billing and coding
To learn more about this program, please click on the
“Learn More” button or the logo of your medication below.
Click on the Medication Below for Information or to Enroll:
Before prescribing ONTRUZANT, please read the accompanying Prescribing Information, including the Boxed Warning about cardiomyopathy, infusion reactions (pulmonary toxicity), and embryo-fetal toxicity.
Before prescribing RENFLEXIS, please read the accompanying Prescribing Information, including the Boxed Warning about serious infections and malignancies. The Medication Guide also is available.